USP and Alphalyse have qualified beta-lactoglobulin (LACB) as a cross-platform standard for LC-MS/MS analysis of Host Cell Proteins (HCPs), addressing inconsistencies in HCP quantitation across different labs. This development ensures more consistent and reliable results, crucial for regulatory compliance and quality control in biopharmaceutical production.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



